The post-reproductive Fallopian tube: Better removed?

Human Reproduction

Volumn 26, Issue 11, 2011, Pages 2918-2924

  Dietl, J ^a   Wischhusen, J ^a   Hausler S F M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

cancer prevention; Fallopian tube; hysterectomy; ovarian cancer; sterilization

Indexed keywords

ACETIC ACID; MISOPROSTOL; SODIUM CHLORIDE;

AREA UNDER THE CURVE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; FEMALE; GAS CHROMATOGRAPHY; GESTATIONAL AGE; HUMAN; HYSTERECTOMY; PH; PREGNANCY TERMINATION; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; REVIEW; SALPINGECTOMY; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; UTERINE TUBE;

EID: 80054886641     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der274     Document Type: Review

References (59)

1. Arnold LD, Colditz GA. Hysterectomy with oophorectomy: implications for clinical decision making. Arch Intern Med 2011;171:768-769.
2. Bartz D, Greenberg JA. Sterilization in the United States. Rev Obstet Gynecol 2008;1:23-32.
3. Basu D, Ward SJ. Post-hysterectomy fallopian tube prolapse-a diagnostic pitfall. J Obstet Gynaecol 2007;27:324. (Pubitemid 46676390)
4. Blank SV. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. Obstet Gynecol 2011; 117:404.
5. Boeckxstaens A, Devroey P, Collins J, Tournaye H. Getting pregnant after tubal sterilization: surgical reversal or IVF? Hum Reprod 2007; 22:2660-2664. (Pubitemid 47434209)
6. Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, Muto MG, Kindelberger D, Crum CP. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 2008;26:4160-4165.
7. Carvalho JP, Carvalho FM. Is Chlamydia-infected tubal fimbria the origin of ovarian cancer? Med Hypotheses 2008;71:690-693.
8. Chene G, Penault-Llorca F, Le Bouedec G, Mishellany F, Dauplat MM, Jaffeux P, Aublet-Cuvelier B, Pouly JL, Dechelotte P, Dauplat J. Ovarian epithelial dysplasia after ovulation induction: time and dose effects. Hum Reprod 2009;24:132-138.
9. Chi IC, Jones DB. Incidence, risk factors, and prevention of poststerilization regret in women: an updated international review from an epidemiological perspective. Obstet Gynecol Surv 1994; 49:722-732. (Pubitemid 24296707)
10. Chiaffarino F, Parazzini F, Decarli A, Franceschi S, Talamini R, Montella M, La Vecchia C. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer. Gynecol Oncol 2005;97:318-322. (Pubitemid 40614870)
11. Cibula D, Widschwendter M, Zikan M, Dusek L. Underlying mechanisms of ovarian cancer risk reduction after tubal ligation. Acta Obstet Gynecol Scand 2011;90:559-563.
12. Dar P, Sachs GS, Strassburger D, Bukovsky I, Arieli S. Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod 2000;15:142-144. (Pubitemid 30035115)
13. Dietl J, Wischhusen J. The forgotten fallopian tube. Nat Rev Cancer 2011; 11:227.
14. Falkeborn M, Schairer C, Naessen T, Persson I. Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol 2000;53:832-837. (Pubitemid 30609648)
15. Ghezzi F, Cromi A, Siesto G, Bergamini V, Zefiro F, Bolis P. Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? BJOG 2009;116:589-593.
16. Green A, Purdie D, Bain C, Siskind V, Russell P, Quinn M, Ward B. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer 1997;71:948-951. (Pubitemid 27252873)
17. Greene MH, Mai PL. What have we learned from risk-reducing salpingo-oophorectomy? J Natl Cancer Inst 2009;101:70-71.
18. Greene MH, Mai PL, Schwartz PE. Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol 2011;204:19.e1-19.e16.
19. Hickey M, Ambekar M, Hammond I. Should the ovaries be removed or retained at the time of hysterectomy for benign disease? Hum Reprod Update 2010;16:131-141.
20. Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M, Sarto GE, Robbins J, Phillips L, Martin LW et al. Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med 2011;171:760-768.
21. Karst AM, Levanon K, Drapkin R. Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc Natl Acad Sci USA 2011; 108:7547-7552.
22. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 2007;31:161-169. (Pubitemid 46175016)
23. Kurman RJ, Shih le M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010;34:433-443.
24. Lawrence RE, Rasinski KA, Yoon JD, Curlin FA. Factors influencing physicians' advice about female sterilization in USA: a national survey. Hum Reprod 2011;26:106-111.
25. Lawrie TA, Nardin JM, Kulier R, Boulvain M. Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database Syst Rev 2011;2:CD003034.
26. Leblanc E, Narducci F, Farre I, Peyrat JP, Taieb S, Adenis C, Vennin P. Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development. Gynecol Oncol 2011; 121:472-476.
27. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garder J, Birch C, Mou H, Gordon RW et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 2007; 211:26-35. (Pubitemid 46092026)
28. Manchanda R, Abdelraheim A, Johnson M, Rosenthal A, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E et al. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG 2011;118:814-824.
29. Marquez RT, Baggerly KA, Patterson AP, Liu JS, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 2005;11:6116-6126. (Pubitemid 41262937)
30. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW, Crum CP. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006;30:230-236. (Pubitemid 43740193)
31. Morse AN, Hammer RA, Walter AJ, Baker S, Magtibay PM. Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? Am J Obstet Gynecol 2002;187:1483-1486. (Pubitemid 36026674)
32. Morse AN, Schroeder CB, Magrina JF, Webb MJ, Wollan PC, Yawn BP. The risk of hydrosalpinx formation and adnexectomy following tubal ligation and subsequent hysterectomy: a historical cohort study. Am J Obstet Gynecol 2006;194:1273-1276.
33. National Cancer Institute DoCCaPS, Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) Program. SEER 12 Incidence and Mortality, DevCan Database. Bethesda, MD, USA: National Cancer Institute, 2004.
34. Ness RB, Goodman MT, Shen C, Brunham RC. Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer. J Infect Dis 2003;187:1147-1152. (Pubitemid 36399357)
35. Parker WH, Shoupe D, Broder MS, Liu Z, Farquhar C, Berek JS. Elective oophorectomy in the gynecological patient: when is it desirable? Curr Opin Obstet Gynecol 2007;19:350-354. (Pubitemid 47067098)
36. Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu ZM, Shoupe D, Berek JS, Hankinson S, Manson JE. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol 2009a;113:1027-1037.
37. Parker WH, Jacoby V, Shoupe D, Rocca W. Effect of bilateral oophorectomy on women's long-term health. Womens Health (Lond Engl) 2009b;5:565-576.
38. Petersen HB, Pollack AE, Warshaw JS. Tubal sterilization. In: Rock JA, Jones HW (eds). TeLinde's Operative Gynecology. Philadelphia: J.B. Lippincott, 2008.
39. Piacenza JM, Salsano F. Post-hysterectomy fallopian tube prolapse. Eur J Obstet Gynecol Reprod Biol 2001;98:253-255. (Pubitemid 33713904)
40. Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, Gille JJ, Jongsma AP, Pals G, Kenemans P et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001; 195:451-456. (Pubitemid 33069670)
41. Pinheiro SP, Hankinson SE, Tworoger SS, Rosner BA, McKolanis JR, Finn OJ, Cramer DW. Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev 2010;19:1595-1601.
42. Przybycin CG, Kurman RJ, Ronnett BM, Shih le M, Vang R. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 2010; 34:1407-1416.
43. Repasy I, Lendvai V, Koppan A, Bodis J, Koppan M. Effect of the removal of the Fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2009; 144:64-67.
44. Rezvani M, Shaaban AM. Fallopian tube disease in the nonpregnant patient. Radiographics 2011;31:527-548.
45. Rivera CM, Grossardt BR, Rhodes DJ, Brown RD Jr, Roger VL, Melton LJ III, Rocca WA. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009;16:15-23.
46. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-1083. (Pubitemid 47517552)
47. Schepens JJ, Mol BW, Wiegerinck MA, Houterman S, Koks CA. Pregnancy outcomes and prognostic factors from tubal sterilization reversal by sutureless laparoscopical re-anastomosis: a retrospective cohort study. Hum Reprod 2011;26:354-359.
48. Schmidt JE, Hillis SD, Marchbanks PA, Jeng G, Peterson HB, Sterilization UCR. Requesting information about and obtaining reversal after tubal sterilization: findings from the US Collaborative Review of Sterilization. Fertil Steril 2000;74:892-898.
49. Semmel DR, Folkins AK, Hirsch MS, Nucci MR, Crum CP. Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria. Mod Pathol 2009;22:985-988.
50. Sezik M, Ozkaya O, Demir F, Sezik HT, Kaya H. Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res 2007;33:863-869. (Pubitemid 350086521)
51. Shaw PA, Rouzbahman M, Pizer ES, Pintilie M, Begley H. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers. Mod Pathol 2009; 22:1133-1138.
52. Shwayder JM. Pelvic pain, adnexal masses, and ultrasound. Semin Reprod Med 2008;26:252-265. (Pubitemid 351770195)
53. Singla A. An unusual case of torsion hydrosalpinx after hysterectomy: a case report. Aust N Z J Obstet Gynaecol 2007;47:256-257. (Pubitemid 46909311)
54. Stock RJ. Histopathologic changes in fallopian tubes subsequent to sterilization procedures. Int J Gynecol Pathol 1983;2:13-27. (Pubitemid 13045061)
55. Timor-Tritsch IE, Monteagudo A, Tsymbal T. Three-dimensional ultrasound inversion rendering technique facilitates the diagnosis of hydrosalpinx. J Clin Ultrasound 2010;38:372-376.
56. Tone AA, Begley H, Sharma M, Murphy J, Rosen B, Brown TJ, Shaw PA. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma. Clin Cancer Res 2008;14:4067-4078.
57. Vitonis AF, Titus-Ernstoff L, Cramer DW. Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy. Obstet Gynecol 2011;117:1042-1050.
58. Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM, Marchbanks PA. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008;198:34 e31-37.
59. Yossry M, Aboulghar M, D'Angelo A, Gillett W. In vitro fertilisation versus tubal reanastomosis (sterilisation reversal) for subfertility after tubal sterilisation. Cochrane Database Syst Rev 2006;3:CD004144.